已知的肺腺癌致癌驱动(根源)基因 和 靶药
ALK - Crizotinib克药, LDK378, AP26113, CH5424802
BRAF - share targeted therapy with melanoma drug, Vemurafenib
EGFR - 特罗凯, 易瑞莎, 2992阿法替尼, WZ4002,凡德它尼
HER2 - share targeted therapy with breast cancer, herceptin,2992,PF299804
KRAS - no targeted therapy available currently(暂时没药)
MET - Crizotinib克药, and prostate cancer drug cabozantinib XL-184
PIK3CA - BLM120(有YL药了)
RET - share targeted therapy with GIST and kidney cancer drug, Sunitinib(索坦); leukemia drug ponatinib; thyroid cancer drug Vandetanib(凡德); and prostate cancer drug Cabozantinib (XL184)
ROS - Crizotinib克药, AP26113
T790M - WZ4002,CO-1686,AZ9291